Skip to search formSkip to main contentSkip to account menu

CRL 42796

Known as: CRL-42796, CRL42796 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

DipeptidesSulfonamides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Glycoprotein IIb/IIIa Receptor Antagonist (2S)-2-[(2-Naphthyl-sulfonyl)amino]-3-{[2-({4-(4-piperidinyl)-2-[2-(4-piperidinyl)ethyl] butanoyl}amino)acetyl]amino}propanoic Acid Dihydrochloride (CRL42796…
The antithrombotic effect of the glycoprotein IIb/IIIa (GPIIb/IIIa) antagonist (2S)-2-[(2-naphthyl-sulfonyl)amino]-3-{[2-({4-(4… 
2003
2003
Prevention of Carotid Artery Thrombosis After Oral Administration of the Glycoprotein IIb/IIIa Antagonist CRL42796
&NA; This study investigates the effect of the glycoprotein IIb/IIIa receptor antagonist CRL42796 in a canine model of carotid… 
2003
2003
butanoyl } amino ) acetyl ] amino } propanoic Acid Dihydrochloride ( CRL 42796 ) , in Combination with Aspirin and / or Enoxaparin , Prevents Coronary Artery Rethrombosis after Successful…
The antithrombotic effect of the glycoprotein IIb/IIIa (GPIIb/IIIa) antagonist (2S)-2-[(2-naphthyl-sulfonyl)amino]-3-{[2-({4-(4… 
2002
2002
Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796
The antithrombotic effect of the glycoprotein IIb/IIIa receptor antagonist, CRL42796, was examined in canine models of carotid… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)